Twitter with OTEurope

Article

It would probably be safe to assume that everyone reading this piece will have at least heard of Twitter; even if they are not actually using it. However, knowing that Twitter is out there and using it effectively are two very different things.

It would probably be safe to assume that everyone reading this piece will have at least heard of Twitter; even if they are not actually using it. However, knowing that Twitter is out there and using it effectively are two very different things.

www.twitter.com/oteurope will take you to Ophthalmology Times Europe's Twitter page and allows you to keep in touch with people and exchange information. Twitter is a microblogging platform that is increasingly being used as a business communication channel. It has different uses for different people but we think its value probably lies in a combination of broadcasting information and engaging in conversations with others.

It is a powerful medium to use for communicating with friends, colleagues and communities with shared interests. There are over three million registered users including ophthalmologists. We hope you find it useful and another method of keeping in touch with the ophthalmic community.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.